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Calcium Channel Blockers as Precipitating or Exacerbating Factors in Hospitalized
Patients with Psoriasis Vulgaris: A Case Control Study
A.D. Cohen, M. Kagen, M. Friger,* and S. Halevy
Department of Dermatology and *Department of Epidemiology and Health Services Evaluation, Soroka
University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva,
Israel
Background In vitro evidence suggests that intracellular calcium metabolism in¯uences
keratinocytes differentiation. However, only few reports described exacerbation of psoriasis or
psoriasiform eruptions due to intake of calcium channel blockers.
Objectives We conducted a case-control study in order to evaluate the association between
exposure to calcium channel blockers and psoriasis or psoriasiform eruptions.
Methods Data were obtained through a retrospective assessment of the ®les of 150 patients
hospitalized for psoriasis or psoriasiform eruptions in the Department of Dermatology and 150
matched control patients. Exposure to calcium channel blockers was recorded in case and control
patients. F-Step multivariate logistic regression model was used for analysis of data.
Results Calcium channel blockers were taken by 13 patients in the case group as compared to 3
patients in the control group. Exposure to calcium channel blockers was signi®cantly associated
with psoriasis (odds ratio: 4.6, 95% con®dence intervals; 1.2±21.0). Calcium channel blockers were
associated with precipitation of new onset psoriasis (n = 2), as well as with the exacerbation of
existing psoriasis (n = 11), but not with psoriasiform eruptions. 3/13 patients (23.1%) had palmo-
plantar involvement and 1/13 patients (7.7%) had a positive family history of psoriasis. The calcium
channel blockers consumed by the patients were as follows: nifedipine (n = 10), felodipine (n = 2)
and amlodipine (n = 1). The median latent period between the beginning of intake of calcium
channel blockers and precipitation or exacerbation of psoriasis was 28 months, ranging from 4 to
143 months. Seven patients had concomitantly taken beta blockers. A multivariate logistic
regression analysis demonstrated that intake of calcium channel blockers was signi®cantly associated
with psoriasis (p < 0.02).
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Gender Differences in Quality of Life of Subjects with Psoriasis
D. Abeni, P. Pasquini, M.M. Chren, C. F. Melchi, E. Mazzotti, O. Picconi, F. Sera and the I.D.I.
Multipurpose Psoriasis Research On Vital Experiences (IMPROVE) investigators
Clinical Epidemiology Unit, IDI-IRCCS, Rome, Italy
Objective To describe health-related quality of life (QOL)of subjects with psoriasis, and to
explore which conditions are linked to poorer levels of QOL.
The Italian version of the Skindex-29 QOL questionnaire was administered to subjects with
psoriasis seen at IDI from Feb.-Aug. 2000. Higher scores indicate poorer QOL.
Results A total of 377 subjects (227 males) agreed to participate, and 369 (97.9%) completed the
Skindex-29. The overall total Skindex-29 mean scores were 40.0 for males and 49.1 for females.
Scores were consistently higher for females in all subscales (data not shown). Factors associated with
poorer quality of life both for males and females were SAPASI, physicians' severity rating, arthritis
(self-reported), symptoms (e.g. pruritus, burning), and lesions on the palms of the hands.
Males Females
Variable Levels N Scores p-value N Scores p value
Age at onset (years) <15 19 32.7 0.150 22 37.7 <0.001
15±29 91 38.3 51 44.0
30±39 35 44.2 19 47.4
40+ 82 41.7 50 59.9
BMI (NIH classif.) <18.5 ± ± 0.456 10 41.4 0.061
18.5-24.9 70 41.6 61 45.3
25.0-29.9 100 38.0 34 49.4
30+ 54 41.2 32 57.8
Lesions on face No 152 38.9 0.293 105 46.8 0.092
Yes 73 41.9 34 54.4
Lesions on genitals No 54 39.1 0.299 105 46.3 0.033
Yes 171 42.3 34 55.9
Conclusions Older age at onset, obesity, and lesions on the face or on the genitals are associated
with poorer quality of life only in women. Dermatologists should be aware that similar ``objective''
levels of severity imply a higher disease burden for women.
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Incidence of Atopic Dermatitis Among Children in Denmark During the 1990s. Results
of Two Population Based Studies
A. B. Olesen, K. Bang, S. Juul, and K. Thestrup-Pedersen
Department of Dermatology & Department Epidemiology and Social Medicine, University Hospital of
Aarhus, Denmark
Objectives To study the 1993 and 1998 cumulative incidence of atopic dermatitis at age 7 among
children born in Denmark in order to throw light on possible changes of the incidence during the
1990s. Further to study a possible association between atopic dermatitis and socio-economic
factors, i.e. Maternal/parental educational level.
Methods Historical follow-up among two random samples of children born in Denmark from
1984 to 1994 drawn from the Danish Medical Birth Register. Data was collected by: mailed
questionnaire collecting data on atopic dermatitis using the UK diagnostic algorithm and physician
diagnosis; the Danish National Population Register collecting data on deaths, emigrations and
family members; the Children's database at Statistics Denmark collecting data on maternal and the
highest parental educational level.
Results In 1993 the cumulative incidence of atopic dermatitis at age 7 was 18.9% among 1060
children (response rate 93%). In 1998 the cumulative incidence rate at age 7 was 19.6% among
9744 children (response rate 79%). In the study performed in 1998 the cumulative incidence of
atopic dermatitis at age 14 using a physician diagnosis was 20.1% in the families with the lowest
educational level and 20.6% in the families with the highest educational level; p-value
(trend) = 0.28. Using the UK diagnostic algorithm did not change the result substantially.
Conclusions No difference in the age-adjusted atopic dermatitis incidence at age 7 was observed
within the 5 years observation period in Denmark during the 1990s. Maternal/parental educational
level was not associated with the incidence of atopic dermatitis neither using the physician
diagnosis nor the UK diagnostic algorithm.
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The Italian Epidemiological Study on Atopic Dermatitis (SEIDA): Prevalence in
9-Year-Old Children
D. Abeni, F. Sera, F. Ayala,* E. Bonifazi,² P. Fabbri,³ C. Gelmetti,§ G. Monfrecola,*
A. Peserico,¶ S. Seidenari,** G. Giannetti,** and G. Girolomoni
IDI-IRCCS, Rome, and the Departments of Dermatology of the Universities of *Naples, ²Bari, ³Florence,
§Milan, ¶Padua, **Modena, Italy
Objective To estimate the prevalence of atopic dermatitis (AD) in a population of 9-year-old
children in different Italian areas, and to investigate factors associated with presence of AD.
Methods To minimize sampling variability we used a proportional sampling design, with children
selected in 4 geographical areas according to the distribution (by sex, age, and region) reported in the
13th Italian general census. In each participating center the number of children was proportional to the
population of the sampled city. In each city, using systematic sampling, the appropriate number of
schools was chosen, and within each school classes were selected using simple random sampling
without replacement. The total target population (hypothetical AD prevalence 0.14, a = 0.05,
b = 0.20, exposure prevalence [data not shown] 0.50±0.10,minimumdetectable signi®cant difference
OR 1.6±2.0) was 1444 children. Parents and teachers answered standardized questionnaires on
potential risk factors, and children were examined by an experienced dermatologist. AD was de®ned
according to the UK Working Party's diagnostic criteria for AD.
Results Overall, 1356 children were visited, and 88 had AD (6.7*%, 95%CI 5.3±8.1 [*estimates
corrected for sampling design]). The area and sex speci®c estimates are summarized below:
Males Females Total
Area N AD (%) N AD (%) N AD (%)
North-West 129 5 3.9 126 4 3.2 255 9 3.5
North-East 85 10 11.2 79 7 9.3 164 17 10.3
Central 175 3 1.9 171 8 4.7 346 11 3.3
South 319 30 9.4 272 21 7.2 591 51 8.3
Overall 708 48 6.8 648 40 6.2 1356 88 6.7*
Conclusions This is the ®rst Italian population-based study estimating prevalence of AD.
Although it is limited to 9-year-old schoolchildren in urban/metropolitan areas, it provides sound
evidence on the occurrence of AD in this population. This information should be useful for
associations of patients and their families, teachers and other educational workers, dermatologists,
and health care planners and providers.
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The NHS Systematic Review of Treatments for Atopic Eczema
C. Hoare, A. Li Wan Po,* and H. Williams²
National Eczema Society, London, *Centre of Evidence-Based Pharmacotherapy, Aston, ²Centre of
Evidence-Based Dermatology, Nottingham, UK
Objectives This scoping review sought to produce an up-to-date ``map'' of randomized
controlled trials (RCTs) of interventions for the prevention and treatment of atopic eczema in
order to identify research gaps and, where possible, to inform treatment recommendations.
Methods Data sources included electronic searching of MEDLINE, EMBASE, the Cochrane
Controlled Clinical Trials Register, the Cochrane Skin Group Register, handsearches of
conference proceedings, follow-up of citations in articles and personal contacts with researchers
and industry. Only RCTs where a physician diagnosed atopic eczema were included. 2 people
conducted data extraction, and eligible studies were quality-rated and quantitatively summarized
where possible.
Results Although a total of 1165 possible RCTs were identi®ed, 893 of these had to be excluded
due to lack of appropriate data. The 272 remaining RCTs covered at least 47 different treatment
interventions. Quality of reporting was generally poor. Statistical pooling was only possible for oral
cyclosporin. Although there was reasonable RCT evidence to support interventions such as topical
corticosteroids and ultraviolet light, there was insuf®cient evidence to make recommendations on
some interventions such as allergen avoidance, evening primrose oil and topical doxepin. There
was no convincing RCT evidence to suggest any clear bene®t to avoidance of enzyme washing
powders, biofeedback, twice-daily as opposed to once-daily topical steroids, topical steroid/
antibiotic combinations and antiseptic bath additives. There was a complete absence of RCT on
issues such as oral prednisolone, wet-wrap bandages and salt baths.
Conclusions The evidence base for atopic eczema is characterized by a profusion of short-term
trials of `me too' products, a lack of common outcome measures which measures things that are
important to patients, poor standards of trial reporting and lack of data on questions that people
with atopic eczema and their physicians deem to be important.
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Topical Steroids in Mild to Moderate Eczema ± Short Bursts of Strong Preparations or
Continuous Use of Mild Ones?
K. Thomas, H. Williams, A. Avery, A. Li Wan Po A,* S. Armstrong, and J. Lenton
University of Nottingham, UK and *Aston University, Birmingham, UK
Background Topical corticosteroids have been in use for over 40 years to treat atopic eczema, yet
it is still not known if using a strong steroid for a short burst is better than milder ones. There is a
large variation in practice surrounding this issue, re¯ecting the lack of evidence.
Objectives (a) To demonstrate that a 3-day burst of a potent steroid, followed by a 4-day rest
period, is more effective in treating disease exacerbations and in maintaining remissions in children
with atopic eczema, when compared with weak preparations used for longer periods; (b) To
establish that such a ``short burst'' regimen does not increase the frequency of thinning of the skin.
Methods 174 community and 33 hospital patients participated with mild to moderate atopic
eczema. This was a randomized, double-blind, parallel group study of 8-week duration. Two
primary outcomes were examined (i) the number of relapses and (ii) the number of days free of
scratching. Other secondary outcomes included the number of nights during which sleep was
disturbed; the number of treatment failures in each arm; a severity index (SASSAD); two quality-
of-life measures (CLQI, DFI) and change in skin thickness as measured by B-mode ultrasound.
Results Data collection is due for completion by March 2001. Preliminary results will be
presented at the meeting.
Conclusion Atopic eczema is usually a chronic relapsing disease. This study provides new data on
the effects of different topical corticosteroid regimens on disease chronicity as well as short-term
control.
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A Twin Study of Eczema and other Atopic Disorders in a Large UK Female Population
R. Mikkilineni,* D. Strachan,² H. Snieder,* T. D. Spector,* and V. Bataille*²³
*Twin Research and Genetic Epidemiology Department and ³Dermatology Department, St Thomas
Hospital, London, ²Department of Epidemiology, St George's Hospital Medical School, London, U.K
Objectives and methods We sought by use of a classical adult twin study to investigate the
relative contribution of genetic and environmental effects on the expression of eczema and further
to explore the relationship between eczema and other atopic disorders such as hay fever and
asthma. A cotwin control analysis and a cross sectional study were carried out with potential risk
factors for eczema examined by comparing twins with eczema to those without. 456 monozygotic
(MZ) twin pairs and 1090 dizygotic (DZ) pairs with a mean age of 46 years (18±79) were recruited
between 1996 and 2000 from the St Thomas UK Adult Twin Register. History of eczema, hay
fever and asthma was ascertained via a validated questionnaire in addition to other demographic
and epidemiological data. Model-®tting analyses were performed to quantify the genetic and
environmental components of the variance in eczema. Conditional logistic regression was used to
analyze 139 MZ and 356 DZ twin pairs discordant for eczema.
Results The prevalence of eczema was 31% in both MZ and DZ twins. The case-wise
concordance for eczema was 0.53 in MZ compared with 0.38 in DZ. The best ®tting model
showed that 61% of the variance in eczema was explained by additive genetic factors (95% CI, 49±
72%) and the remaining 39% by unique environmental effects (95% CI 28±51%). Analyses of twin
pairs discordant for eczema yielded odds ratios for hay fever associated with eczema of 1.8 (95% CI
0.96±3.4, p = 0.07) and 1.4 (95% CI 0.96±2.0, p = 0.08) for MZ and DZ twins, respectively. The
odds ratio for asthma associated with eczema in discordant MZ twins was 1.6 (95% CI 0.95±3.5,
p = 0.24) and was 1.0 (95% CI 0.63±1.6, p = 1.0) in discordant DZ twins. However, in unmatched,
analyses of the overall twin population using the General Estimating Equation, signi®cant
association was also observed between eczema and asthma for both MZ and DZ twins.
Conclusions Genetic effects are important in the development of atopic dermatitis with 61% of
the variance explained by genetic effects. An elevated risk of eczema in the presence of hay fever
and possibly asthma persisted in the MZ discordant pairs suggesting that environmental factors are
also critical in the expression of atopic phenotypes. Further studies will investigate genetic
correlations between these atopic phenotypes. (This work was funded in part by MRC, Wellcome,
ARC, Chronic Diseases Research Fund and Genomics).
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Epidemiology of Food Allergy in Adults: Associations with Atopy
T. SchaÈfer,*² E. BoÈhler,* S. Ruhdorfer,* L. Weigl,* D. Wessner,* J. Heinrich,³ B. Filipiak,³ H.
E. Wichmann,³§ and J. Ring*²
*Department of Dermatology and Allergy, Technical University Munich, ²Division Env. Dermatology and
Allergy GSF I TUM, ³GSF-Institute of Epidemiology, Neuherberg, §Institute of Medical Data Processing,
Biometrics, and Epidemiology, Munich University, Germany
Objective Food allergy is believed to be a frequent medical problem, however, information from
epidemiological studies in adults is scarce. We determined the frequency of adverse reactions and
allergic sensitization to food in a large adult sample. Furthermore, the associations between food
allergy and other outcomes of atopy were studied.
Methods Within a population-based, nested case-control-study a standardized interview was
performed to obtain detailed information on adverse food reactions and the history of atopic
diseases. In addition a skin prick test with 10 common food and nine aeroallergens was performed.
Results Overall, 20.8% of the 1537 studied subjects (50.4% female, age median 50 years) reported
adverse food reactions (women 27.5%, men 14.0%; OR 2.35, CI 1.80±3.08). Nuts, fruits, and milk
most frequently led to adverse effects and the sites of manifestation were oral (42.9%). skin (28.7%),
gastrointestinal (13.0%), systemic (3.2%), and multiple (12.2%). One quarter of the subjects (25.1%)
was sensitized to at least one food allergen in the prick test, with hazelnut l7.8%), celery (14.6%),
and peanut (11.1%) accounting for most of the positive reactions. The corresponding frequency
estimates for the representative study base (n = 4178) were 15.5% for reported adverse reactions and
16.8% for allergic sensitization. Relevant cross sensitization between food and aeroallergens were
observed. Food allergic subjects (positive history and sensitization to corresponding allergen)
suffered signi®cantly more often from urticaria. asthma, atopic eczema and especially hay fever
(89.1%) than controls (8.1%; p < 0.001). Furthermore, hay fever was treated signi®cantly more
often in subjects who suffered from concomitant food allergy.
Conclusion Food allergy in adults is frequently reported and if associated with hay fever tends to
aggravate the latter since therapeutic needs are enhanced.
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Incidence Rates of Irritant Contact Dermatitis in Different Occupational Groups
H. Dickel, O. Kuss, A. Schmidt,* and T. L. Diepgen
Department of Clinical Social Medicine, University of Heidelberg and *Bavarian State Department of
Occupational Medicine, Nuremberg, Germany
Objectives Irritant contact dermatitis (ICD) is believed to be more frequent the cause for
occupational skin diseases (OSD) than allergic contact dermatitis (ACD). However, one has to
consider that a distinction between ICD and ACD can be dif®cult, because of the simultaneous
exposure to irritant and sensitizing agents playing an essential part in the development of
occupational contact dermatitis. We conducted a population-based prospective study to identify
occupational ``high-risk'' groups for ICD. The data are based on all cases of workers' disability
claims reported to our Register of OSD (BKH-N) in North Bavaria, Germany.
Methods In the time period from 1990 to 1999, 5285 cases were closed and recorded. Due to the
cooperation with the German State Institute of Labor and Occupation and the known number of
employees in the occupations we were able to calculate the incidence rates in different occupations
classi®ed to 24 groups.
Results In the 24 occupational groups in 3097 (58.6%) cases (38.7% males, median age 25 years)
an QSD was stated with an overall annual incidence rate of ICD of 3.8 cases per 10 000 workers
and of ACD of 3.5 cases per 10 000 workers, respectively. The highest incidence rate of ICD was
found in hairdressers (46.9), bakers (23.5), and pastry cooks (16.9), while the highest incidence rate
of ACD was in hairdressers (67.2), ¯orists (15.5), and tile setters and terrazzo workers (13.7). ICD,
without ACD, was the main reason of OSD in pastry cooks (75.6%), cooks (69%), food-processing
industry and butchers (63%), mechanics (60%), locksmiths and automobile mechanics (58.8%),
housekeepers, restaurant business, cleaners (56.3%), and bakers (55.7%). A positive patch test result
of occupational relevance was detected in 1611(52.0%) cases.
Conclusions In analyzing the risk factors for work-related ICD, the incidence ®gures of the
BKH-N are of great value. ``High-risk'' groups with exposure to irritants at the workplace are
highlighted. Irritants mostly involved are water (wet work), detergents and cleansing agents, hand
cleaners, chemicals, cutting ¯uids, and abrasives, with wet work being the most important one.
The results assist in working out tools (e.g. German regulation of hazardous substances at the
workplace of recent date: TRGS 531 ``wet-work'') which might have an essential impact on the
prevention of work-related ICD.
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The Problem of Grading Hand Eczema
A.M. van Coevorden and P.J. Coenraads
Departrnent of Dermatology, University Hospital Groningen, the Netherlands
Objectives Hand eczema is a disease entity with a high prevalence among patients seen in the
general practitioner's and dermatologist's practice. Although a number of therapeutic options are
available, clinicians are often confronted with its chronic relapsing course and its unfavorable
prognosis. This prompted us to review the clinical evidence underlying the therapeutic options
discussed in the major textbooks. Assessing the severity of hand eczema in these studies confronted
us with a methodological problem. In contrast to diseases such as psoriasis and atopic eczema, for
which scoring systems (e.g. PASI, EASI, SCOPAD) are available, hand eczema lacks such a widely
used and validated tool to assess its severity and/or its extend. Therefore, we set up a study to
evaluate which parameters of outcome are used in papers assessing the treatment of hand eczema.
Methods We searched computer databases, ranging from 1966 (Medline) and 1989 (Embase)
through 2001, and the Cochrane databases for clinical trials and therapy oriented case reports
concerning hand eczema. All dermatological journals and other major medical journals from 1977
through 2001 were hand searched. In addition, we went through the reference lists of the
previously found papers. We restricted our search to papers written in English or German.
Results So far, over the period 1966±2001 78 papers were identi®ed, of which 27 were
randomized controlled trials. A quick scan of the methodology sections of these papers revealed a
wide variety of unvalidated outcome parameters.
Conclusions The information derived from (grouping of) different scoring systems and endpoints
will enable us to make a more rational choice of these parameters for future studies.
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Occurrence of Hand Eczema in Swedish Adults ± Changes in Prevalence Between 1983
and 1996
B. Meding*² and B. JaÈrvholm³
*Occupational Dermatology, National Institute for Working Life, Stockholm, ²Department of Medicine,
Occupational and Environmental Dermatology, Karolinska Institutet, Stockholm, ³Occupational Medicine,
Department of Public Health and Clinical Medicine, UmeaÊ University, Sweden
Objectives To study changes in the prevalence of hand eczema in Swedish adults.
Methods Two cross-sectional studies were performed in 1983 and 1996, respectively. Random
samples from the population of GoÈteborg of age 20±65 years were drawn from the population
register. Data were collected by a postal questionnaire, which was identical in the two studies. The
response rate was 83.5% (16,708/20 000) in 1983 and 73.9% (2218/3000) in 1996.
Results The reported 1-year prevalence of hand eczema decreased from 11.8% in 1983 to 9.7% in
1996 (p < 0.0 L). The largest difference was found in the youngest age group. However reported
childhood eczema increased from 10.4% to 12.4% (p < 0.01). Of those with childhood eczema
27.9% and 25.2% reported hand eczema, in comparison to 10.0% and 7.5% among those without
childhood eczema. In total 76.8% were gainfully employed in 1983 and 68.3% in 1996 (p < 0.001).
In 1983 23.0% were employed in ``high-risk'' occupations for hand eczema compared to 19.4% in
1996 (p < 0.001). The difference was largest in the youngest age group.
Conclusions The study indicates that the prevalence of hand eczema in Swedish adults had
decreased between 1983 and 1996 despite an increasing prevalence of childhood eczema. The most
probable cause is a decreased occupational exposure to skin irritants. Thus, this study shows that
occupational factors are important predictors of hand eczema.
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Self-Reported Hand Eczema ± Symptom-Based Reports do Not Increase the Validity
AÊ . Svensson,* M. Lindberg,² B. Meding,²³ K. Sundberg,§ and B. Stenberg¶
*Department of Dermatology, University Hospital, MalmoÈ, ²Department of Medicine, Occupational and
Environmental Dermatology. Karolinska Institutet, Stockholm, ³Occupational Dermatology, National
Institute for Working Life, Stockholm, §Department of Dermatology. LaÈnssjukhuset Ryhov, JoÈnkoÈping,
¶Department of Public Health and Clinical Medicine, Division of Dermatology and Venereology, University
Hospital, UmeaÊ, Sweden
Objectives Hand eczema affects about 10% of the general population of working ages. There is
an interest to ®nd validated cost-effective means of epidemiological surveillance.
Methods Consecutive patients (N = 95) referred because of hand eczema and persons in an
ongoing epidemiologic survey (N = 113) participated in the study. Before seeing an experienced
dermatologist they (a) had to answer a short questionnaire about current signs and symptoms from
the hands. (b) state if they had hand eczema on the day of examination. The minimum criteria of
hand eczema diagnosed by the dermatologist (``gold standard'') were de®ned as erythema and
papules/vesicles or erythema and scaling and ®ssures/licheni®cation.
Results Of the 208 examined persons 93 ful®lled the criteria for hand eczema according to the
`gold standard'. Hand eczema diagnosis based on clinical signs reported in the questionnaire by the
participants gave a sensitivity of 0.62 and a speci®city of 0.87 in comparison with the
dermatologists diagnoses. Regarding the question about current hand eczema the agreement was
good between the judgements of the participants and thc dermatologists giving a sensitivity of 0.87
and a speci®city of 0.79. Comparing clinical signs reported by the participants and the ®ndings by
the dermatologists showed the best agreement for ®ssures, with a kappa value of 0.65 (CI 95%,
0.55±0.75) and the lowest kappa value was found for papules 0.47 (CI 95%, 0.32±0.62).
Conclusion In the present study was shown that it is dif®cult for the individual person to identify
skin signs compatible with the clinical diagnosis of hand eczema. However it was demonstrated
that asking `Do you have hand eczema?' had high sensitivity and speci®city compared to the
suggested gold standard for hand eczema.
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Relative Contribution of Genes and Ultraviolet Radiation in the Expression of Naevi.A
UK Adult Twin Study
V. Bataille,*³ H. Snieder,* P. Sasieni,² and T. D. Spector*
*Twin Research and Genetic Epidemiology Department and ³Dermatology Department, St Thomas
Hospital, London, ²Department Maths, Stats and Epidemiology, ICRF, London, U.K
Objectives Studies comparing total body naevus counts (TBNC) between Australia and the UK have
shown that ultraviolet radiation (UVR) signi®cantly in¯uences numbers of naevi in both children and
adults. This twin study was set up to investigate the relative contribution of genetic and environmental
factors on the variance in TBNC and to examine potential associations between high naevus counts and
exposure to natural and arti®cial UVR.
Methods 291 pairs of monozygotic (MZ) female twins and 791 pairs of dizygotic (DZ) female twins
(mean age 43 years) recruited from the St Thomas UK Adult Twin Registry underwent a skin examination
with naevus counts performed by trained examiners. Data on sun and sunbed exposure as well as number of
sunburns and skin type were also collected.
Results The mean TBNC was 34 (0±362). Age was negatively associated with TBNC (p < 0.0001).
Table 1 shows the intrapair correlations for MZ and DZ, respectively.
Trait or exposure No of sunburns Use of sunbed Weeks abroad TBNC Skin type
r(MZ) 0.87 0.80 0.54 0.53 0.58
r(DZ) 0.50 0.30 0.38 0.38 0.52
Analyses of variance in Mx showed that up to 55% of the variance in TNBC was attributed to additive
genetic effects. In a multivariate analysis using General Estimating Equation including all twins, high naevus
counts were significantly associated with sunbed use (p < 0.0001) and age (p < 0.0001) but not with skin
type, number of weeks abroad or number of sunburns. In 480 DZ twin pairs discordant for sunbed use, the
OR for high naevus count was 2.4 (p = 0.06). In 64 MZ pairs discordant for sunbed exposure, the OR for
high naevus count was 1.5 (p = 0.6).
Conclusions These results show that genetic factors are important in the expression of naevi and skin type
but that environmental factors such as sunbed exposure also in¯uences numbers of naevus counts. Future
studies looking at these complex gene±environment interactions with linkage studies are currently
underway. This work was funded in part by MRC, Wellcome, ARC, Chronic Diseases Research Fund
and Gemini Genomics.
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Sun Sensitivity, Sunscreen Use, and the Risk of Dysplastic Nevi
M.A. Weinstock and R. Mikkilineni
Dermatoepidemiology Unit, VA Medical Center and Departments of Dermatology and Community Health,
Brown University, Providence, Rhode Island
Objectives and methods We sought to assess the relation of sun sensitivity and sunscreen use to
dysplastic nevi in a matched case-control study of dysplastic nevi and melanoma. We recruited
1444 subjects who were members of a staff model health maintenance organization between 1989
and 1994. Cases were members diagnosed with dysplastic nevi or melanoma, chosen as a random
sample with selection strati®ed by degree of dysplasia. Controls were individually age and gender
matched to cases. Participants were interviewed by telephone regarding sun sensitivity, sun
exposure, sunscreen use. and other variables. Analyses used logistic regression conditional on the
matched pair; con®rmed family history of melanoma was controlled a priori in all analyses.
Results The odds ratios (OR) of having dysplastic nevi, for the most sun sensitive phenotype vs.
the least, were 1.5 (95% CI 1.3±1.7) for hair color, 1.7 (95% CI 1.3±2.1) for skin color, and 1.8
(95% CI 1.4±2.3) for burning easily in the sun. An index of sun sensitivity was created by averaging
all three of the above variables with equal weights (cronbach's alpha = 0.59). We modeled the
index along with each sun sensitivity variable and found the index to be a better indicator of
dysplastic nevus risk than any of its components alone. The odds of melanoma, any dysplastic nevi,
moderate/severe dysplastic nevi, and mild dysplastic nevi were 10.5 (95%CI 3.3±33.0), 4.3 (95%
CI 2.7±6.8), 5.5 (95% CI 2.5±11.8), and 3.3 (95%CI 1.8±5.8) for the most sun sensitive phenotype
vs. the least. We found the odds of being a case increased with increasing sunscreen use, after
controlling for sun sensitivity. Risk of melanoma, any dysplastic nevi, moderate or severe dysplastic
nevi, or mild dysplastic nevi were similar, with OR = 1.4 (95% CI 1.0±2.0), 1.4 (95% CI 1.2±1.6),
1.5 (95% CI 1.2±1.8), and I.5 (95% CI 1.2±1.7). The results were similar when the analysis was
restricted to those reporting greater than 10 years of regular sunscreen use. Pearson correlation
between sunscreen use (categorized on a 4 point scale) and sun sensitivity was modest (r = 0.25),
but far in excess of chance (p < 0.0001).
Conclusions We have validated our index of sun sensitivity against relevant biologic outcomes,
and documented a direct association between degree of dysplasia in dysplastic nevi and sun
sensitivity. These analyses also indicate that reported sunscreen use is directly associated with the
diagnosis of dysplastic nevus. We hypothesize that an antecedent of the dysplastic nevus diagnosis
causes increased sunscreen use, although the distinction between that hypothesis and the direct
hypothesis that sunscreens cause dysplastic nevi cannot be con®dently inferred from these data.
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Non-Solar Ultraviolet (UV) Light Exposure and the Risk of Dysplastic Nevi
R. Mikkilineni and M.A. Weinstock
Departments of Community Health and Dermatology, Brown University, and Dermatoepidemiology Unit,
VA Medical Center, Providence, Rhode Island
Objectives and methods We sought to assess the relation of arti®cial UV light to the development of
dysplastic nevi and melanoma by analysis of a 1 : 1 age and gender matched case-control study of members
of a staff model health maintenance organization between 1989 and 1994. Cases (n = 722) were members
diagnosed with dysplastic nevi or melanoma, chosen as a random sample with selection strati®ed by degree
of dysplasia. Variables of interest were ascertained by telephone interview, and where indicated. interview
of a relative or examination of medical records was performed. Information regarding total years of non-
solar UV exposure and average yearly treatments or uses was ascertained for all participants with a history of
non-solar UV exposure. We analyze the data using logistic regression conditional on matched pair and
controlled for sun sensitivity and a con®rmed melanoma family history of melanoma in all models.
Results 5.8% (84) of the study population reported a history of phototherapy treatment with an overall
odds ratio (OR) of 1.7 (95% CI 1.0±3.0) for dysplastic nevi. Speci®cally, the OR for melanoma was 3.l
(95% CI.9±10.5), for moderate or severe dysplastic nevi was 3.5 (95% CI 1.3±9.8) and for mild dysplastic
nevi was 1.1 (95% CI.6±2.1). Analysis of all dysplastic nevi and total phototherapy exposure, coded:
0 = non-e, 1 = < 50 treatments, and 2 = > 50 treatments, revealed an increased odds of l.5 (95% CI 1.0±2.4)
for each unit increase in exposure. We further analyzed the risk of all dysplastic nevi separately in
individuals with low sun sensitivity (index < 0.5) and high sun sensitivity (index > 0.5) and found odds of
1.4 (95% CI.6±3.1) and 1.7 (95%CI.9±3.3), respectively, without a statistically signi®cant effect
modi®cation. Use of tanning beds or sun lamps was reported by 41% (592). Analysis by ever use of
non-solar recreational UV light showed a OR's of 1.2(95% CI 0.7±2.0) for melanoma only, 1.3 (95% CI
1.0±1.7) for all dysplastic nevi, 1.5 (95% CI 1.0±2.2) for moderate or severe dysplastic nevi, and 1.1 (95%
CI.8±1.4) for mild dysplastic nevi. Analysis of all dysplastic nevi and total tan bed and sun lamp exposure,
coded: 0 = non-e, 1 = < 50 uses, and 2 = > 50 uses, revealed an OR of 1.2 per unit (95% CI 0.8±1.7).
Conclusions The data suggests that there is an increased risk of dysplastic nevi and melanoma associated
with exposure to phototherapy with evidence of a dose±response relation. We have no information about
possible exposure to psoralens. Our analyses do not suggest that recreational non-solar UV is associated
with dysplastic nevi.
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Platelet Derived Growth Factor Gene Polymorphisms are Associated with Non-
Melanoma Skin Cancer Risk in Renal Transplant Recipients
H.M. Ramsay, A.A. Fryer,* P.N. Harden,² M. Shahbazi,³ V. Pravica,³ and I.V. Hutchinson³
Department of Dermatology, *Biochemistry and ²Nephrology, North Staffordshire Hospital, Stoke-on-Trent,
UK; ³School of Biological Sciences, University of Manchester, Manchester, UK
Objectives Non-melanoma skin cancer (NMSC) is a major cause of morbidity following renal
transplantation. Some recipients appear to be at particularly high risk in terms of tumor numbers or
rate of accrual. Although environmental and clinical factors are important, genetic factors are also
likely to in¯uence individual risk. We examined the association between polymorphisms in the
platelet derived growth factor genes (PDGF-A & -B) and NMSC risk.
Methods 182 (95% of population) unrelated Caucasian renal transplant recipients with a mean
(SD) age at transplantation of 38.9 (15.6) years and mean follow-up of 8.5 (6.3) years were
recruited from a single Northern European center. Subjects were interviewed and examined using
a standard proforma by a single dermatologist. All case-notes were carefully reviewed. All
histologically proven NMSC were included in the analysis. DNA was extracted from peripheral
blood leukocytes. PDGF polymorphisms were determined using standard PCR-RFLP
methodology. Logistic regression, negative binomial regression and Cox's proportional hazards
analyses were used to examine the association with NMSC risk, tumor numbers and time from
transplantation to ®rst tumor. Basal and squamous cell carcinomas were considered separately
(BCC, SCC).
Results 16.5% developed NMSC (53 BCC, 28 invasive and 33 in-situ SCC in 18, 11 and 14
patients, respectively) since transplantation. Compared with the wild type A/A genotype, PDGF-
A + 286 G/A was associated with a lower risk (p = 0.047, Odds ratio 0.32, 95% CI 0.1±0.98), and
fewer numbers of BCC (p = 0.008, Rate ratio 0.21, 95%CI 0.07±0.66). Furthermore individuals
with this genotype showed a signi®cantly shorter time from transplantation to ®rst BCC (Hazards
ratio 0.26, 95% CI 0.08±0.80) The homozygous G/G genotype showed similar trends but did not
achieve statistical signi®cance due to lower numbers. Similar, but generally less signi®cant results
were seen for the PDGF-B + 1135 A/C genotype. No signi®cant results were found identi®ed
with SCC or with the PDGF-A + 135 polymorphism.
Conclusions It may prove possible to identify recipients at highest risk of NMSC on clinical and/
or genetic grounds, allowing the development of more targeted surveillance strategies than
generally exist. Con®rmation of these early ®ndings is required in a larger cohort.
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Variants of the Melanocortin-1-Receptor (MC1R) are Associated with Malignant
Melanoma Independent of Skin Type
C. Kennedy, J. ter Huurne, N. Gruis, M. Bastiaens, and J.N. Bouwes Bavinck
Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands
Objectives Variants of the MC1R-gene are associated with fair skin and red hair and increase the
risk for the occurrence of malignant melanoma (MM). The question remains whether MC1R-
gene variants show a causal association with the development of MM or whether MC1R-gene
variants exert their in¯uence via fair skin type.
Methods Utilizing a case-control, 123 patients with non-familial melanoma and 385 controls
were evaluated. Information concerning skin type was collected by utilizing a questionnaire and
dermatological examination. MC1R-gene variants were determined via SSCP and ``direct
sequencing''. Odds ratios were calculated and strati®ed according to skin type and hair color.
Results The presence of MC1R-gene variants was associated with a higher risk for melanoma
independent of skin type and hair color. The melanoma risk was higher when patients possessed
two gene variants as compared to possession of one gene variant. The risk after adjusting for skin
type was 3.6 (95% CI:1.7±7.2) when two variants were present and 2.7(95% CI:1.5±5.1) when one
variant was present. Presence of Asp84Glu and Arg151Cys were associated with the highest
melanoma risks namely 16.1 (95% CI:2.3±13.9) and 7.2 (95% CI:2.9±18.1) when combined with
another variant allele.
Discussion The presence of MC1R-gene variants increase the risk for the development of MM
independent of skin type and red hair. Aside from an in¯uence on melanogenesis, MC1R-gene
variants also have an in¯uence on melanocyte proliferation and immunomodulation which is also
of importance for the development of MM.
SECTION 2: SKIN CANCERS AND PRECURSORS
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Rapidity of Primary Melanoma Growth as a Prognostic Marker
J.J. Grob, M.A. Richard, M.F. Avril, M. Delaunay, J. Gouvernet, P. Wolkenstein, P. Southeyrand,
J.J. Bonerandi, L. Machet, J.C. Guillaume, J. Chevrant-Breton, C. Vilmer, F. Aubin, B. Guillot,
M. Beylot -Barry, C. Lok, N. Raison-Peyron, and P. Chemaly
Club de CanceÂrologie CutaneÂe, France
Objectives There is still a crucial need for prognostic markers in melanoma (MM). The main
objective of this study was to assess whether ``Rapidity of MM Growth'' (RMG) could be a
prognostic factor.
Methods 4 years ago, we conducted an already published large multicenter study to assess the
impact of delays before diagnosis on Breslow thickness. Very precise and exhaustive data about the
history of each MM were thus recorded including: d1 the date when the patient ®rst noticed a
lesion on the site of the MM, d2 the date when the patient ®rst noticed a change in this lesion, and
d3 date of MM removal. Most centers accepted to participate in a new prospective study to obtain
follow-up data in the patients included in the ®rst study. Cases coincidentally detected by doctors
were excluded, since information about d1 and d2 was often missing. RMG can be assessed by the
ratio: ``Breslow thickness/growth-period'' with growth-period de®ned by the time-period between
the starting-point of tumor growth and tumor removal. As MMs often develop on nevi, d2 was
considered to be the representative starting-point for MM growth when studying all cases. In the
subgroup of patients with a d1-d2 < 5 years, MMs were likely to be de-novo, and d1 was
considered more representative of the starting-point for MM growth-period. d2-d3 period was
thus used as an assessment of growth period to calculate RMG in all patients, and d1-d3 period was
used to calculate SMG in probably de-novo melanoma. Follow-up provided the date of 1st relapse,
last visit and death. Cox and logistic models were used to assess the relapse risk according to RMG.
Lg (RMG) was used to take into account the proportionality of RMG rather than the absolute
difference between 2 RMG.
Results In all self-detected primary MMs (328 cases) with a median follow-up of 4 years,
Lg(RMGd1-d3) was found to be a signi®cant risk factor for recurrence (0R = 1.57/1.38±1.79) using
Cox model, and RR for recurrence at 1 years was 2.22 (1.69±2.92) using logistic model. When
Breslow, ulceration, Clark, age and sex were included, Lg(RMGd1-d3) was no more signi®cant in
Cox, but RR was still 1.55 (1.15±2.10) using logistic model. In probably de-novo MMs (i.e. 201
patients with d1-d2 < 5 years), Lg(RMGd2-d3) was signi®cantly predictive of recurrence using Cox
model (OR = 1.84/1.51±2.25) and RR of recurrence at 1st year was 2.93 (1.84±4.69). When
Breslow and usual prognostic markers were included, Lg (RMGd2-d3) was still retained just after
Breslow both in Cox model (0R = 1.30/1.06±1.60),and in logistic model with a RR 1.74 (1.21±
2.51) of recurrence at 1 years.
Conclusions This is the ®rst prospective study showing that the rapidity of the growth of a
primary MM, as recorded by the patients, is predictive of an early relapse. It seems to be a risk
marker partly independent from Breslow especially in de-novo MMs. Although it may be dif®cult
to standardize rapidity of growth, in order to use it as a prognostic marker for clinical practice, these
results underline 1/that celerity of tumor growth is probably a relevant assessment of biological
aggressiveness 2/that listening to a patient able to describe his MM history may provide a better
prognostic information than many complex biological tests.
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Do Lipid-Lowering Drugs Prevent Melanoma?
R.P. Dellavalle and L.M. Schilling*
Departments of Dermatology and *Medicine University of Colorado, Denver
Objectives To evaluate the hypothesis that lipid-lowering medications prevent melanoma.
Methods This was a case-control study utilizing computerized hospital Denver Veterans
Administration Medical Center (VAMC) pharmacy and diagnosis databases.
Results Two large, randomized, placebo-controlled trials of lipid-lowering agents, gem®brozil
and lovastatin, have each detected lower melanoma rates in the treated patients of the trials.
Lovastatin has also been shown to inhibit melanoma cell growth in tissue culture, and melanoma
metastasis in mice injected with melanoma cells. The hypothesis that lipid-lowering medication
prevents melanoma was addressed via a melanoma case-control analysis of Denver VMAC
pharmacy and diagnosis patient computer databases. The database yielded 328 melanoma cases.
From 1992 to 2000, the melanoma cases had lower ever-exposure rates to statins (18% vs. 30%) and
®brates (4.9% vs. 5.9%) than a random sample of two thousand control cases.
Conclusions Preliminary evaluation of case-control data revealed lower lipid-lowering
medication use rates among melanoma cases at the Denver VAMC than among controls.
Analysis of the extent and temporal relation of these exposures is underway to determine the
signi®cance of this ®nding. Further evaluation of lipid-lowering medications for the
chemoprevention of melanoma will determine whether randomized trials of these agents should
be initiated in persons at high risk of developing melanoma.
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Cryotherapy vs. Topical 5-Fluorouracil Therapy of Actinic Keratoses: A Systematic
Review
P.E. Pierre, B.A. Weil,* and S.C. Chen²
Department of Dermatology, Stanford University School of Medicine, Stanford, California; *School of
Medicine, University of Toronto; ²Department of Dermatology and the Emory Center for Outcomes
Research, Emory University, School of Medicine, Atlanta, Georgia
Objective To critically review the published body of literature that studied the response of actinic
keratoses to topical 5-¯uorouracil and cryotherapy and to compare the ef®cacy of both treatment
modalities.
Methods Reviewed MEDLINE, EMBASE, and CancerLit from 1966 through October 1999
and proceedings from the AAD meetings (1997±2000) to identify studies of 5-¯uorouracil and
cryotherapy in patients with actinic keratoses. Compared the summary ef®cacy to both the
binomial and chi square distribution using a range of probabilities that an AK will progress to a
malignant tumor.
Results Despite an initial identi®cation of 88 reports of 5-¯uorouracil in the treatment of actinic
keratoses, only 3 could be meta-analyzed because they used different concentrations and/or
vehicles for the drug. In addition, main outcome measures varied widely. Using a ®xed-effect
model, the overall ef®cacy of 5% 5-FU ointment ranged from 79% (using patient-level data) to
84% (using study-level data). Only one study reported quanti®able results for cryotherapy; a cure
rate of 98.8% was achieved. All other cryotherapy studies were qualitative. When compared to
potential natural regression rates of actinic keratoses, 5% 5-FU is better than leaving lesions alone if
the spontaneous regression rate is below 84% (by binomial distribution; 90% for chi-square). There
is no statistical difference (p > 0.05) between 5% 5-FU and leaving the lesions alone if the
spontaneous regression rate falls between 75% and 84% (60%-89% for chi-square).
Conclusions Although cryotherapy is the method of choice in the treatment of actinic keratoses
in everyday practice, there are no studies in the literature evaluating its ef®cacy. Despite the well-
accepted use of topical 5-FU, the supporting data is sparse. A therapy can be judged relative to the
natural regression rates of actinic keratoses. The best available source is the Queensland study but
the comparison with our ®nding should be interpreted with caution as it reports patient outcomes
as number of regressed actinic keratoses rather than persons cleared. Currently, there is no evidence
to justify the Medicare initiative to use 5-FU as ®rst-line treatment for actinic keratoses.
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Association Between Human Papillomavirus Seroreactivity and a History of Multiple
Non-Melanoma Skin Carcinomas
M. Feltkamp, R. Broer, B. Verlaan,² L. Struijk, H. van Loveren,² J. ter Schegget, W. Spaan, and
J.N. Bouwes Bavinck*
Departments of Virology and *Dermatology, Leiden University Medical Center, Leiden, the Netherlands;
²Department of Immunobiology, National Institute of Public Health, the Netherlands
Objectives Epidermodysplasia verruciformis (EV) patients are known to develop multiple
squamous cell carcinomas (SCC) which contain a particular subset of human papillomaviruses
(HPV). These EV-HPV types are also regularly found in non-melanoma skin cancers (NMSC) in
the general population, as well as in healthy skin. In both cases multiple EV-HPV types are
detected, frustrating the search for oncogenic EV-HPV types. In order to investigate EV-HPV
oncogenicity, we studied EV-HPV seroreactivity in NMSC patients and controls.
Methods A case-control study was designed containing individuals with a history of SCC
(n = 161), of nodular (n = 301) and of super®cial multifocal (n = 153) basal cell carcinoma (BCC),
of malignant melanoma (MM) (n = 125), and matched controls (386). All individuals were
interviewed and underwent physical examination with emphasis on skin pathology. Sera from
these individuals were tested in an ELISA using L1 virus like particles from four EV-HPV types
(HPV8, 20, 24 and 38), representatives of all EV-HPV subgroups. ELISA cut-offs were determined
on randomly selected hospital employees (n = 100).
Results Preliminary analyses indicate a positive association between EV-HPV seroreactivity and a
history of multiple NMSC (SCC and/or BCC). EV-HPV seroreactivity was also associated with a
current status of multiple solar keratoses. Both associations were most prominent in males. Solar
keratoses as such and a history of a single SCC or BCC were not associated with EV-HPV
seroreactivity.
Conclusions EV-HPV seroreactivity in patients with a history of non-melanoma skin cancer is
associated with a history of multiple NMSC and a high number of solar keratoses. These data may
suggest that HPV seroreactivity depends on HPV load or, alternatively, that HPV seroreactivity is
short lived. Whether EV-HPV is causally involved in NMSC requires further study.
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Epidemiology of ``senile'' Lentigos: A Case-Control Study
J.J. Grob, S. Monestier, M.A. Richard, and J. Gouvernet
Service de Dermatologie, HoÃpital Sainte Marguerite 13009 Marseille, France
Objectives Incidence of melanoma is increasing in the elderly. The epidemiology of lentigo maligna
(LM), a cancer related to chronic sun-induced skin damage, is different from other melanomas, and no
clear risk marker is yet identi®ed. LM may be linked to senile lentigos (SLs), like carcinoma to solar
keratoses. However, nothing is known about the epidemiology of SLs (lentigo senilis, solar lentigos,
actinic lentigines or liver spots). They are mainly located on the face, the dorsum of the hands, and the
external side of the forearms in elderly people. They are distinct from lentigos simplex, freckles, solar
keratoses, and seborrheic keratoses. Although they are a common feature of ageing, they do not
develop in all people, and their density is highly variable. A case-control study was conducted to
identify and assess the risk factors for developing a high density of SLs.
Methods In patients between 60 and 80, not followed for skin diseases or severe chronic
conditions, consecutive cases who presented with a very high number of SLs on the face were
recruited up to ful®lling 30 individuals (15m, 15f) per 5-year age-section, i.e. a total of 120 cases.
Similar procedure was used to enroll 120 individuals with no SL on the face.
Results 120 cases and 120 age- and sex-matched controls were thus recruited. Risk of having a
high number of SLs on the face increased signi®cantly in people with dark skin type, high number
of solar keratoses, marked skin aging features (wrinkles, guttate hypomelanosis, skin laxity) and
number of SLs on the forearms, hands and back. In patients with a high number of SLs, the total
life amount and the last-10 years amount of leisure sun exposure, and the estimation of total
number of sunburns, were found to be signi®cantly increased. The occupational cumulative
exposure was not signi®cantly different in cases and controls. No link was found with hormonal
factors, or number of nevi on the trunk. In multivariate analysis, last 10 years-cumulative leisure
exposure, total number of sunburns, and skin type were retained.
Discussion In contrast with freckles and nevi, multiple SL develop mainly in dark skin type. In
contrast with usually admitted concepts for sun-aging, SLs seem to develop in people submitted to
a high total cumulative amount received through intermittent exposure, rather than through
regular exposure. A regular sun exposure is however, required since SL occurred mainly on the
face and forearms.
Conclusions Unexpectedly, high number of SLs does not appear to be a marker of regular
exposure in light-skinned people, but rather a marker of life-cumulative excess of intermittent
exposure in easy-tanners who still expose themselves late in their life. A study of SL as risk markers
for lentigo maligna is warranted.
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Is the MC1R-Gene the Freckle-Gene?
M.T. Bastiaens, J.A.C. Ter Huurne, N.A. Gruis, W. Bergman, R.G.J. Westendorp, B.J. Vermeer,
and J.N. Bouwes Bavinck
Department of Dermatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, the
Netherlands
Objectives Ephelides (freckles) and solar lentigines are different types of pigmented skin lesions.
Ephelides appear early in childhood and are associated with fair skin type and red hair. Solar
lentigines appear with increasing age and are a sign of photo damage. Both lesions are strong risk
indicators for melanoma and non-melanoma skin cancer. Melanocortin-1 receptor (MC1R) gene
variants are also associated with fair skin, red hair and skin cancer. The purpose of this study was to
investigate the relation between MC1R-gene variants, ephelides and solar lentigines.
Methods In a large case-control study patients with melanoma and non-melanoma skin cancer,
and subjects without a history of skin cancer were studied. Of all participants the presence of
ephelides in childhood and solar lentigines by physical examination was assessed according to strict
de®nitions. In the analyses, ephelides were divided into absent and present, and solar lentigines
were divided into non-severe and severe. The entire coding sequence of the MC1R gene was
analyzed by Single Stranded Conformation Polymorphism analysis followed by sequence analyses.
Results Carriers of one or two MC1R-gene variants had a 3 and 11-fold increased risk of
developing ephelides, respectively (both p < 0.0001), whereas the risk of developing severe solar
lentigines was 1.5 and 2-fold increased (p = 0.035 and p < 0.0001), respectively. These associations
were independent of fair skin type and red hair, and were comparable in patients with and without
a history of skin cancer.
Conclusions As nearly all individuals with ephelides were carrier of at least one MC1R-gene
variant, our data suggest that MC1R-gene variants are necessary to develop ephelides. The results
of the study also suggest that MC1R-gene variants play a role in the development of solar
lentigines.
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Relative Contribution of Cumulative Solar Ultraviolet A vs. B Radiation Exposure to
Skin Photoageing: An Epidemiological Study
D. Battistutta,*² G. Strutton,³ G. Williams,§ and A. Green*
*Queensland Institute of Medical Research Brisbane; ²Queensland University of Technology, Brisbane;
³Princess Alexandra Hospital, Brisbane; §University of Queensland, Brisbane, Australia
Objectives Both ultraviolet-A (UVA) and ultraviolet-B (UVB) radiation have been implicated in
skin photoageing, a multifaceted phenomenon of clinical, cellular, histological, and immunological
changes. Much of the in vivo evidence of the relationship between wavelength-dependent
ultraviolet radiation exposure and photoageing has been based on animal models. This study
considered the relative contributions of UVA and UVB radiation exposure to the hallmark feature
of photoageing, degree of dermal elastosis, in an unselected human population.
Methods An age-strati®ed random sample of 338 adults aged over 17 years was chosen from the
electoral roll of the community of Nambour, Australia. Subjects were recruited between May 1994
and May 1995, and asked to provide a 2-mm punch biopsy of the skin of the back of the left hand,
and to complete a one-page sun exposure questionnaire from which several indices of ultraviolet
radiation exposures were de®ned. Haematoxylin±and-eosin stained sections were assessed for
degree of dermal elastosis on a scale from 0 (no evidence of elastotic ®bres) to 6 (severe elastosis).
Multiple linear regression models considered the association between ultraviolet radiation exposure
indices and dermal elastosis grade.
Results Lifetime sun exposure hours and actinic UVA exposure were both associated with degree
of dermal elastosis in a log-linear relationship (p < 0.001). These associations persisted after
strati®cation for skin color. No consistent trends were demonstrated for either, total hours of sun
exposure between 10am and 2 pm, or actinic UVB exposure.
Conclusions UVA exposure is more clearly implicated in the accumulation of dermal elastosis
than is UVB exposure. Since the majority of ultraviolet radiation is composed of UVA, and given
the association between photoageing and skin cancer, this effectively suggests that public health
messages should emphasize equal avoidance of all sun exposure.
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The Value of Dermato-Epidemiology in the Development of a Schools Education
Program
R. Marks, K. Merlin, A. Plunkett, and J. Campbell
St. Vincent's Hospital Melbourne; Skin & Cancer Foundation, Victoria, Australia
Objectives School-based studies on the frequency of common skin conditions revealed that
warts, tinea pedis, acne and atopic dermatitis were suf®ciently common to suggest the need for an
education program. Data collected in the original study showed also a lack of understanding of
these conditions and where they should seek advice by adolescents and their parents.
Methods Development of a skin health education program on common skin conditions was
undertaken. An education package for teachers and a resource for students and parents was
produced. Resources were piloted and then delivered to every secondary school in the State of
Victoria, Australia. Follow up evaluation included surveying the 524 schools to which the program
was developed.
Results A 70% response rate from the teachers revealed 91% had said they received the resources,
of these 62% had incorporated them into the current curriculum. Of the remaining 38%, 95%
planned to use them in next year's curriculum, as a library resource or in some other way. An in-
depth telephone interview of a sample of teachers who had used the material revealed that over
80% of teachers considered their resource to be useful or very useful with the majority claiming it
to be very useful. An intervention study on 249 students from six Victorian secondary schools
tested students prior to and post delivery of the education program. There was an increase in
knowledge for each of the areas covered by the education program. There was some variation
according to the school which was related to the particular teacher involved and the way in which
they used the resources.
Conclusions In summary, epidemiology was used as a tool to assess needs in relation to common
skin conditions in school students in Victoria, Australia. It was also used to develop, a pilot, deliver,
and assess the effectiveness of an education program to be used on the basis of the demonstrated
need. This model is now being used to develop further education programs on common skin
conditions for primary schools and the preschool Maternal and Child Health Service in Victoria.
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The Effect of a Brief Nurse-Delivered Intervention Utilizing Digital Photographs on
Patient Adherence with Skin Self-Examination
S.A. Oliveria, P.J. Christos, D.L. Phelan, J.S. Ostroff, J.L. Hay, and A.C. Halpern
Departments of Medicine and Psychiatry, Memorial Sloan-Kettering Cancer Center, New York, New York
Objectives The identi®cation and excision of thin lesions may be important in reducing mortality
from melanoma. Results from a single case control study suggest that skin self-examination has the
potential to reduce mortality from melanoma by 63%. Despite these encouraging results, little is
known about patients' adherence in performing skin self-examination to detect new or changing
moles. The purpose of this pilot study was to assess the impact of a brief nurse-delivered
intervention utilizing digital photographs on patients' adherence to performing skin self-
examination.
Methods Patients at high risk for skin cancer (5 or more dysplastic nevi) (n = 34) were recruited
from the outpatient clinic at Memorial Sloan-Kettering Cancer Center. All participants had
baseline whole-body digital photography as part of their clinical evaluation. Patients were
randomized: Group A (n = 20) received a teaching intervention (physician encounter and nurse
education module) with a photo book (personal whole-body photographs compiled in the form of
a booklet with nurse instruction) and Group B (n = 14) received the teaching intervention only
without a photo book. A self-administered questionnaire was given to the patient at three time
points: baseline, after the delivery of the interventions at the baseline visit, and at 4 months post
baseline visit.
Methods To assess skin self-examination, we asked patients, ``How many times in the past
4 months did you (or someone else) thoroughly examine your skin.'' Results: In Group A (teaching
intervention with photo book), 5% of the patients at baseline reported skin examination 3 or more
times during the past 4 months, while at the 4 month follow-up, 55% reported skin examination 3
or more times (p = 0.039 for paired comparison). Fourteen percent of the patients at baseline in
Group B (teaching intervention only) reported skin examination 3 or more times during the past
4 months; at the 4 month follow-up, 29% reported skin examination 3 or more times (p = 0.63).
We compared the increase in reported skin examination between the two groups (+ 50%
vs. + 15%, p = 0.083).
Conclusions Our results suggest that a brief nurse-delivered intervention is effective at increasing
patient adherence with skin self-examination. Utilizing digital photographs as an adjunct to
screening appears to increase patient adherence to performing skin self-examination.
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Hospital Waiting Lists Subject to Power Law Distributions
D.P. Smethurst and H.C. Williams
Center of evidence-based Dermatology, Queen's Medical Center, University Hospital, Derby Road,
Nottingham, U.K
Objectives To see whether waiting list activity may be described by the power law distributions
that govern self-organizing phenomena and complex systems.
Methods Monthly waiting list ®gures were analyzed for four dermatology consultants over seven
years in a similar way to Mandelbrot's analysis of monthly cotton prices published in 19631. The
percentage change in waiting time to see a particular consultant from one month to the next was
calculated and a frequency distribution for these changes then generated.
Results Evidence for 1/fa (signal dependant) noise in the frequency distribution for the
percentage monthly variation in waiting list length was discovered. The frequency of occurrence of
a particular size of change was dependent upon that size. A straight-line logarithmic plot (R = 0.92,
p < 0.00005) of this distribution for waiting list ®gures suggests that it is a self-organized
phenomenon.
Conclusions We have demonstrated a real application of complexity theory to health services
research. Ef®ciency within the waiting lists system is perversely implied because of the fundamental
nature of self-organizing systems2. This ef®ciency is not of the conventional type. Forest ®res,
disease epidemics and the slopes of a pile of sand are all subject to similar power laws and defy
minor or moderate interventions. The extent to which waiting lists can be altered or manipulated is
questioned in light of these ®ndings.
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Patient and Referring Provider Satisfaction with Teledermatology
M.A. Weinstock, F.Q. Nguyen, and P. Risica
Dermatoepidemiology Unit, VA Med Center, RI Hosp., Memorial Hosp. of RI, and Brown University,
Providence, Rhode Island
Objectives and methods In response to a clinical need within the Veterans Health
Administration, and in the context of limited staf®ng and ®scal austerity, we implemented a
teledermatology consultation service using the store-and-forward approach. The patients were
referred by their primary care clinician to the service, staffed by a nurse practitioner or physician
assistant, who captured and transmitted the data and images, which were then reviewed by the
teledermatologist. The impression and plan was then transmitted back to the nurse practitioner/
physicians assistant, who discussed the results with the patient, performed skin biopsies if needed,
and arranged follow-up. Our study evaluated patient and provider satisfaction.
Results Of the 1030 patient visits with this service, 100 randomly selected patients completed a
telephone interview (89% of those eligible or possibly eligible). The mean age was 61 years and
95% were men. 86% (19) of the primary care clinicians who referred patients responded to this
survey. The program was rated excellent or good at treating their skin condition by 41%, and 52%
felt that the clinic did an excellent or good job of meeting their health care needs. 75% of the
patients said they would recommend the program to someone they knew. Patient comments
mentioned: (1) the clinician-patient relationship, which many commented was poor due to lack of
direct contact with the treating dermatologist (37%); (2) the long waiting time for an appointment
with the teledermatology clinic (22%); (3) inadequacies in follow-up (21%); (4) the absence of
written feedback (5%); and (5) accessibility to the site where the teledermatology clinic was held
(4%). Privacy concerns were rarely mentioned. 74% of providers said they would recommend the
program to another provider. The same percentage rated the written feedback as excellent or good,
and that the usefulness of the program as excellent or good. Clinician comments focused on the
lengthy process to get the teledermatology consultation and associated backlog of referrals, and
inadequacies in follow-up by the teledermatology clinic.
Conclusions Our evaluation indicates that both patients and clinicians generally viewed this
program as useful and would recommend it to a friend or colleague. The main concern expressed
by patients was the lack of direct contact with their dermatologist. Other concerns of both patients
and providers related to resources devoted to the service. A teledermatology consultation is a
dermatology consultation split in place and, with the store-and-forward approach, in time. The
result is a great need for communication, and the potential for inadequate communication and
delay, as well as loss of the direct dermatologist-patient relationship, which is important to patients.
In return a needed service is provided that was previously unavailable.
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Do Estrogens Protect Against the Development of a Chronic Wound?
D. Margolis
Department of Dermatology, Biostatistics & Epidemiology, University of Pennsylvania, Philadelphia,
Pennsylvania
Objectives Pressure ulcers and venous leg ulcers affect a signi®cant portion of the population.
Both of these chronic wounds are more common in the elderly (age 65). They occur due to
repetitive insults requiring the patient to repeatedly attempt to repair cutaneous structure. When
the patient fails to successfully repair a chronic wound occurs. Several lines of laboratory and
clinical evidence have implicated that estrogen supplementation may positively mediate wound
repair.
Methods To that end, we utilized a 10% random sample of elderly patients in the General
Practice Research Database from the UK to investigate the association of hormone replacement
therapy on the incidence of pressure ulcers and venous leg ulcers. Previously validated criteria were
used to ascertain those with venous leg ulcers or pressure ulcers. A Cox proportional hazards model
was used to estimate the instantaneous relative risk (RR) with 95% con®dence intervals (CI) for
hormone replacement (HRT) use and the onset of one of these two chronic wounds.
Results Approximately 42 000 elderly individuals were evaluated and 1744 had a venous leg
ulcer, 802 had a pressure ulcer, and 5006 used HRT. Users of HRT were signi®cantly less likely to
develop a venous leg ulcer (RR: 0.60, 95% CI: 0.50,0.73) or a pressure ulcer (RR: 0.68 95% CI:
0.51,0.91) than non-users. The risk of venous leg ulcer (RR: 1.07 95% CI: 1.06, 1.08) and pressure
ulcer (RR: 1.11 95% CI: 1.10, 1.12) increased with age (per year). Age did not confound the
HRT point estimate nor was an age by HRT interaction noted. Finally, the HRT point estimates
were not confounded by history of deep venous thrombosis, cellulitis, myocardial infarction,
osteoporosis, diabetes, congestive heart failure, or cerebral vascular accident.
Conclusion This observational study demonstrates that HRT may prevent two different chronic
wounds. This was hypothesis-generating study. De®nitive understanding of the effect of HRT on
chronic wounds would require a randomized controlled trial.
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Scalpdex: A Quality of Life Instrument for Scalp Dermatitis
S.C. Chen, J. Yeung,* and M.M. Chren²
Department of Dermatology and Emory Center for Outcomes Research, Emory University, Atlanta, Georgia;
*University of Toronto, Ontario Canada; ²Departments of Dermatology and Medicine, University of
California at San Francisco (SF) and the Dermatology Service, SF Veterans Affairs Medical Center, San
Francisco, California
Objectives An instrument that can quantify scalp dermatitis-related quality of life would be
helpful for both physicians and pharmaceutical companies. Although there are several generic
cutaneous quality of life (QOL) instruments, a scalp dermatitis-speci®c survey does not exist.
Methods Based on the results of directed focus sessions with 8 patients with scalp psoriasis and
seborrheic dermatitis, we conceptualized three major constructs that explain the way scalp
dermatoses affect patients' QOL: symptoms (sx), functioning (fcn), and emotions (em). We
constructed a 23-item instrument, Scalpdex. We tested the validity, reliability, and responsiveness
of the instrument by interviewing patients at baseline, 72 h, and 1 years. We also compared the
results of Scalpdex to that of Skindex, a generic cutaneous QOL instrument to determine its
discriminant validity.
Results 52 Stanford dermatology patients completed the study; 25 had psoriasis and 27 had
seborrheic dermatitis. We demonstrated construct validity by con®rming that the factors derived
by principal axes factor analyses with orthogonal rotation correlated to our hypothesized scales
(r = 0.76±0.84) and that differences in sx, fcn, and em scores differed among the varying levels of
self-reported scalp severity than would be expected by chance (p < 0.05 by ANOVA). The
instrument demonstrated reliability with internal consistency (Cronbach's a: 0.62±0.93) and
reproducibility (intraclass correlation coef®cient: 0.90±0.97). To test responsiveness, baseline and
1-year scores were compared in subjects who either improved (18), worsened (3), or did not
change (31). The QOL scores changed in the expected direction (p < 0.05, by paired t-test for fcn
and em) for those who improved. We found no signi®cant differences in the scores of those who
reported no change. We expected and found no signi®cant difference in the scores of the
worsening category given the small number of patients. We ascertained discriminant capability of
Scalpdex from Skindex by demonstrating superior responsiveness (p < 0.05 by paired t-test in fcn
and em) and differentiation among self-rated severity levels.
Conclusions This study represents the ®rst QOL instrument speci®cally for patients with scalp
dermatitis that is reliable, valid and responsive. Clinicians can use the instrument to determine
which aspect of the disease most bothers the patient and to evaluate QOL as one parameter of
responsiveness to the therapeutic intervention.
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Three Studies on Psychiatric Morbidity in Dermatological Outpatients
P. Pasquini, A. Picardi, C.F. Melchi, and D. Abeni
Clinical Epidemiology Unit, IDI-IRCCS, Rome, Italy
Objective It is commonly believed that psychiatric disorders are frequent among dermatological
patients. However, epidemiological studies are not abundant. We performed a series of studies to
estimate the magnitude of the problem and to identify factors associated the presence of psychiatric
disorder.
Methods Two prevalence studies were carried out. In both studies, all adults attending the
outpatient clinics of a dermatological hospital on predetermined days were given a questionnaire
comprising the 12-item General Health Questionnaire (GHQ-12). The dermatologists indicated
the diagnosis and the location of skin lesions, and rated the disease severity. Also, a longitudinal
study was performed. The GHQ-12 was used to identify subjects free from psychiatric morbidity at
their ®rst dermatological visit. It was administered again after one month during a computer-
assisted telephone interview to identify new cases. In the course of this interview, subjects also
rated the course of their skin disease on a 5-point scale.
Results In the ®rst study, complete data were available for 2579 subjects. Using a stringent cut-off
threshold for psychiatric case identi®cation, the prevalence of psychiatric morbidity was 25.2%
(95% C.I. 23.6%-27.0%). The prevalence was higher in females and in widows/widowers,
controlling for age and marital status. Health-related quality of life was a much stronger predictor
of psychiatric morbidity than physician-rated clinical severity. In the second study, 389 patients
with complete information were included in the analysis. The prevalence of psychiatric morbidity
was 20.6% (95% C.I. 16.7%-25.0%). Again, we found higher probability of psychiatric disorders in
females, controlling for age, clinical severity, and localization of lesions. In females, but not in
males, the prevalence of psychiatric morbidity was higher in patients with lesions on the face or
hands. A total of 277 subjects identi®ed as non-cases at baseline were included in the incidence
study. At the follow-up interview, 21 (7.6%) subjects were identi®ed as psychiatric cases. Lack of
improvement was the only variable associated with increased incidence of psychiatric morbidity
(13.6%), with an odds ratio of 3.1 (95% C.I. 1.2±7.8) adjusting for gender, age, educational level,
and clinical severity.
Conclusions have depicted the situation that is actually faced by dermatologists in their daily
practice. The high prevalence of psychiatric disorders is an issue to be recognized. The
identi®cation and appropriate management of psychiatric morbidity is important. It seems that
dermatologists should be particularly alert to the possibility of a concurrent psychiatric disorder in
female patients with lesions on the face or the hands, and in patients suffering from a disease that is
not improving with treatment.
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